Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Curr Opin Rheumatol Retrieve available abstracts of 14 articles: HTML format

Single Articles

November 2023
1. COHEN S, Reddy V
   Janus kinase inhibitors: efficacy and safety.
   Curr Opin Rheumatol. 2023;35:429-434.
   PubMed     Abstract available
   
   
   September 2023
2. NEUMANN E, Heck C, Muller-Ladner U
   Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis.
   Curr Opin Rheumatol. 2023 Sep 13. doi: 10.1097/BOR.0000000000000978.
   PubMed     Abstract available
   
   
   May 2023
3. DEFOE M, Bermas BL
   Rheumatologic immune checkpoint inhibitor-related adverse events.
   Curr Opin Rheumatol. 2023;35:141-148.
   PubMed     Abstract available
   
   
   April 2023
4. MANTEL I, Fein MR, Donlin LT
   Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets.
   Curr Opin Rheumatol. 2023 Apr 10. doi: 10.1097/BOR.0000000000000940.
   PubMed     Abstract available
   
   
   February 2023
5. MINHAS D, Murphy A, Clauw DJ
   Fibromyalgia and centralized pain in the rheumatoid arthritis patient.
   Curr Opin Rheumatol. 2023 Feb 13. doi: 10.1097/BOR.0000000000000929.
   PubMed     Abstract available
   
   
   
6. ZACCARDELLI A, Wallace ZS, Sparks JA
   Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic.
   Curr Opin Rheumatol. 2023 Feb 8. doi: 10.1097/BOR.0000000000000930.
   PubMed     Abstract available
   
   
   November 2022
7. KINGSMORE KM, Lipsky PE
   Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus.
   Curr Opin Rheumatol. 2022;34:374-381.
   PubMed     Abstract available
   
   
   September 2022
8. LORENTZON M, Abrahamsen B
   Osteoporosis epidemiology using international cohorts.
   Curr Opin Rheumatol. 2022;34:280-288.
   PubMed     Abstract available
   
   
   July 2022
9. IZNARDO H, Puig L
   Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes.
   Curr Opin Rheumatol. 2022;34:225-234.
   PubMed     Abstract available
   
   
   May 2022
10. LUIS M, Boers M, Saag K, Buttgereit F, et al
    The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence.
    Curr Opin Rheumatol. 2022;34:179-186.
    PubMed     Abstract available
    
    
    March 2022
11. ANASTASIOU C, Yazdany J
    Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
    Curr Opin Rheumatol. 2022;34:95-102.
    PubMed     Abstract available
    
    
    November 2021
12. BIRRU TALABI M, Himes KP, Clowse MEB
    Optimizing reproductive health management in lupus and Sjogren's syndrome.
    Curr Opin Rheumatol. 2021;33:570-578.
    PubMed     Abstract available
    
    
    September 2021
13. SATTUI SE, Crow MK, Navarro-Millan I
    The role of immunomodulatory medications in the treatment of COVID-19.
    Curr Opin Rheumatol. 2021;33:431-445.
    PubMed     Abstract available
    
    
    
14. RANDELL RL, Becker ML
    Safety updates in novel therapeutics for pediatric rheumatic disease.
    Curr Opin Rheumatol. 2021;33:403-408.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: